150 related articles for article (PubMed ID: 35085891)
41. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein.
Rajsbaum R; Albrecht RA; Wang MK; Maharaj NP; Versteeg GA; Nistal-Villán E; García-Sastre A; Gack MU
PLoS Pathog; 2012; 8(11):e1003059. PubMed ID: 23209422
[TBL] [Abstract][Full Text] [Related]
42. The E3 Ligase TRIM25 Impairs Apoptotic Cell Death in Colon Carcinoma Cells via Destabilization of Caspase-7 mRNA: A Possible Role of hnRNPH1.
Nasrullah U; Stanke K; Recknagel V; Bozkurt S; Wurzel P; Gauer S; Imre G; Münch C; Pfeilschifter J; Eberhardt W
Cells; 2023 Jan; 12(1):. PubMed ID: 36611995
[TBL] [Abstract][Full Text] [Related]
43. RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ.
Tang H; Li X; Jiang L; Liu Z; Chen L; Chen J; Deng M; Zhou F; Zheng X; Liu Z
Cancer Sci; 2022 Sep; 113(9):3071-3084. PubMed ID: 35701858
[TBL] [Abstract][Full Text] [Related]
44. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
[TBL] [Abstract][Full Text] [Related]
45. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW
Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510
[TBL] [Abstract][Full Text] [Related]
46. MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.
Wang AQ; Lv M; Xu YH; Xie PM; Dong YY
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9860-9868. PubMed ID: 33090389
[TBL] [Abstract][Full Text] [Related]
47. Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome.
Gupta S; Ylä-Anttila P; Callegari S; Tsai MH; Delecluse HJ; Masucci MG
PLoS Pathog; 2018 Jan; 14(1):e1006852. PubMed ID: 29357390
[TBL] [Abstract][Full Text] [Related]
48. LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to Inhibit DNMT3B-mediated methylation of the PHIP promoter.
Ren G; Li H; Hong D; Hu F; Jin R; Wu S; Sun W; Jin H; Zhao L; Zhang X; Liu D; Huang C; Huang H
BMC Cancer; 2023 Sep; 23(1):898. PubMed ID: 37742010
[TBL] [Abstract][Full Text] [Related]
49. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
[TBL] [Abstract][Full Text] [Related]
50. ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target.
Fu J; Zhang J; Chen X; Liu Z; Yang X; He Z; Hao Y; Liu B; Yao D
Theranostics; 2023; 13(2):787-809. PubMed ID: 36632213
[TBL] [Abstract][Full Text] [Related]
51. E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF induced cell necrosis.
Mei P; Xie F; Pan J; Wang S; Gao W; Ge R; Gao B; Gao S; Chen X; Wang Y; Wu J; Ding C; Li J
Cell Death Differ; 2021 Oct; 28(10):2888-2899. PubMed ID: 33953350
[TBL] [Abstract][Full Text] [Related]
52. The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development.
Zhang Q; Li X; Cui K; Liu C; Wu M; Prochownik EV; Li Y
Cell Death Differ; 2020 Feb; 27(2):420-433. PubMed ID: 31186535
[TBL] [Abstract][Full Text] [Related]
53. All Paths Lead to TRIM25.
Zhou H; Costello JC
Trends Cancer; 2017 Oct; 3(10):673-675. PubMed ID: 28958384
[TBL] [Abstract][Full Text] [Related]
54. Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells.
Yao D; You J; Yang X; Zhang J; Yao X
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2242601. PubMed ID: 37533352
[TBL] [Abstract][Full Text] [Related]
55. Deltex E3 ubiquitin ligase 3 inhibits colorectal cancer cell growth and regulates cell cycle progression via upregulating E2F transcription factor 1.
Xu H; Liang S; Hu J; Liu W; Dong Z; Wei S
Mol Biol Rep; 2022 Mar; 49(3):1661-1668. PubMed ID: 35098394
[TBL] [Abstract][Full Text] [Related]
56. C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis.
Huang S; Li J; Wu S; Zheng Z; Wang C; Li H; Zhao L; Zhang X; Huang H; Huang C; Xie Q
Oncogene; 2023 Apr; 42(17):1333-1346. PubMed ID: 36882524
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
Ge T; Liu T; Guo L; Chen Z; Lou G
Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
[TBL] [Abstract][Full Text] [Related]
58. TRIM25 and its emerging RNA-binding roles in antiviral defense.
Choudhury NR; Heikel G; Michlewski G
Wiley Interdiscip Rev RNA; 2020 Jul; 11(4):e1588. PubMed ID: 31990130
[TBL] [Abstract][Full Text] [Related]
59. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.
Qin X; Qiu F; Zou Z
Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193
[TBL] [Abstract][Full Text] [Related]
60. An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis.
Walsh LA; Alvarez MJ; Sabio EY; Reyngold M; Makarov V; Mukherjee S; Lee KW; Desrichard A; Turcan Ş; Dalin MG; Rajasekhar VK; Chen S; Vahdat LT; Califano A; Chan TA
Cell Rep; 2017 Aug; 20(7):1623-1640. PubMed ID: 28813674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]